Correction: Podocan and adverse clinical outcome in patients admitted with suspected acute coronary syndromes
Saved in:
| Main Authors: | Thomas Andersen, Thor Ueland, Pål Aukrust, Dennis W. Nilsen, Heidi Grundt, Harry Staines, Frederic Kontny |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1650098/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Podocan and Adverse Clinical Outcome in Patients Admitted With Suspected Acute Coronary Syndromes
by: Thomas Andersen, et al.
Published: (2022-05-01) -
Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin
by: Thomas Andersen, et al.
Published: (2023-09-01) -
Correction: Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin
by: Thomas Andersen, et al.
Published: (2025-07-01) -
Markers of T cell activation and exhaustion in plasma are associated with persistent symptoms up to 18 months following mild SARS-CoV-2 infection
by: Thor Ueland, et al.
Published: (2025-05-01) -
Systemic inflammation is an important risk factor and predictor of graft loss and mortality one year after kidney transplantation
by: Torbjørn F. Heldal, et al.
Published: (2025-02-01)